Search by Journal
- HOME
- > Search by Journal
- > Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Volume 15, Issue / 2005


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
In holding of the 15th Japanese circulating Japanese Pharmacological Society Shun Tamaoki daylight Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 1-1, 2005. |
---|
![]() |
The Y1 aldosterone activates ERK1/2 of the kidney fibroblast and stimulates a collagen production Yukiko Nagai 1, West 2, Yamanari, Kayoko Miyata 1, Akira Miyatake 1, Masaji Kimura 2, Good luck home Masanori 3, Yoichi Abe 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 17-17, 2005. |
---|
![]() |
The hyperglycemia stimulation produces BMK1 activation and a cell proliferation through Mine Lalo corticoid receptor in Y2 culture mesangial cells Kayoko Miyata 1, West 2, Yamanari, Yuki Suzaki 3, Yuki Izawa 3, Masaji Kimura 2, Shun Tamaoki daylight 3, Good luck home Masanori 4, Yoichi Abe 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 18-18, 2005. |
---|
![]() |
The Y3 aldosterone aggravates myocardial ischemia through non-genome effects Masashi Fujita 1, Tetsuo Minamino 1, Akio Hirata 1, Masatsugu Hori 1, North wind Masashi 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 19-19, 2005. |
---|
![]() |
It is blood vessel relaxant effect discovery (1) of the new blood pressure regulation mechanism of the Y4 ACE inhibition peptide Ushida Yusuke, Mitsuru Tanaka, Toshiro Matsui, Kiyoshi Matsumoto Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 20-20, 2005. |
---|
![]() |
It is L-form Ca2+ channel block effects discovery (2) of the new blood pressure regulation mechanism of the Y5 ACE inhibition peptide Mitsuru Tanaka 1, Ushida Yusuke 1, Toshiro Matsui 1, Kiyoshi Matsumoto 1, Reed island Katsuhiro 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 21-21, 2005. |
---|
![]() |
Elucidation of active expression of Y6 N- domain-specific ACE inhibition peptide requirements Yoshiko Masuda, Urasaki beach, wisteria Yukari, Toshiro Matsui, Kiyoshi Matsumoto Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 22-22, 2005. |
---|
![]() |
Simultaneous intake effect of Y7 ACE inhibitor and the hypotension peptide Keisuke Tanaka, 朱暁琳, Toshiro Matsui, Kiyoshi Matsumoto Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 23-23, 2005. |
---|
![]() |
Effect of Na+ channel blocker which gives it to asystolia at the Y8 ischemia / reperfusion and Na+/Ca2+ exchanger inhibitor 茂木奏尊, Field Koichi Nonaka, Satoru Takeo Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 24-24, 2005. |
---|
![]() |
The Y9 natural product ingredient curcumin inhibits cardiac muscle cells hypertrophy through acetylated suppression in the myocardial cell nuclei Tatsuya Morimoto 1, Wataru Ono 2, Akihisa Kawamura 2, Tooru Kita 1, Koji Hasegawa 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 25-25, 2005. |
---|
![]() |
Participation of the amyloid oligomer in Y10 CryAB RI20G cardiomyopathy clinical condition Atsushi Sanbe, Jeffrey Robbins, Akito Tanoe Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 26-26, 2005. |
---|
![]() |
Up stream strategies for treatment for the proarrhythmic matrix resulting for Y11 hypertrophic myocardium Akira Takahara, Atsushi Sugiyama, Sato Yoshioki, Yuji Nakamura, Keitaro Hashimoto Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 27-27, 2005. |
---|
![]() |
Association of increase and the chymase of MMP-9 just after myocardial infarction that we watched in Y12 hamsters Katsuhiro Yoshikawa 1, 2, Shinji Takai 1, Tokuo 1 Kim, Michiko Muramatsu 1, Yoshinori Mino 2, Mizuo Miyazaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 28-28, 2005. |
---|
![]() |
The Y13 sesamin inhibits hypertension by an antioxidant action and NO-producing sthenia effects by the metabolite Daisuke Nakano 1, 郭哲俊 1, Takashi Fujii Kazuko 1, Kenji Ikemura 1, Satake rabbitfish 1, Akitoku Takaoka 1, Yoshiko Ono 2, Yoshinobu Kiso 2, Yasuo Matsumura 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 29-29, 2005. |
---|
![]() |
A PGH2-producing mechanism by the mechanical stress and participation of sPLA2 to the tonic abnormality of the pulmonary hypertension clinical condition blood vessel in Y14 pulmonary artery Tomoki Morikawa 1, Tanabe reason good luck 1, Maki Saito 2, Koichi Nakayama 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 30-30, 2005. |
---|
![]() |
It is the selective expression sthenia with the platelet-derived growth factor a regulation of gene expression mechanism of the neural-type NO synthase in Y15 vessel walls cells Yasushi Nakata, Masato Tsutsui 1, Hiroaki Shimokawa 2, Yasuhide Nakajima, Yanagihara deferred chapter 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 31-31, 2005. |
---|
![]() |
Mechanism - that relaxation response augmentation mechanism - cGMP by the vascular endothelial cells removal in the Y16 rat mesenteric arteries vascular bed is involved Yukiko Iwatani 1, Marsh Hiromi 1, Ability tree Saori 1, Fusako Takayama 1, Mio Koyo 2, Hiromi Kawasaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 32-32, 2005. |
---|
![]() |
The neural NO inhibits sympathetic transmission in Y17 rat mesenteric arteries resistance vessel Yukako Hatanaka 1, Yoshihara Narumi 1, Gold carthamus 1, Shinji Akiyama 1, 丁敏 2, Kobayashi Yuta 2, Fusako Takayama 1, Hiromi Kawasaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 33-33, 2005. |
---|
![]() |
Simultaneous intactness image analysis of the outside free radical dynamics in cells using Y18 nucleus, electronic double resonance imaging apparatus (PEDRI) Kenichi Yamada, Yuichi Kinoshita, Emi Furusato, Makoto Yamato Yumi, Shingo Matsumoto, Tomohiro Nakayama, Kiyoshi Sakai, Hideo Utsumi Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 34-34, 2005. |
---|
![]() |
Y19 Vascular remodeling is promoted by Kafumoderu in T cell-specific HIF1αKO mouse 黒部裕嗣1,3, 冨田修平1, 井澤有紀2, 福原弥生2, 粟飯原賢一4, 赤池雅史4, 神原保3, 松本俊夫4, 北川哲也3, 吉栖正典2, 玉置俊晃2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 35-35, 2005. |
---|
![]() |
Role of transcription factor FOXO3a in differentiation, the growth of Y20 megakaryocytes progenitor cells Takafumi Nakao, Hiroshi Iwao, Kenneth Kaushansky Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 36-36, 2005. |
---|
![]() |
Analysis of the arteriosclerosis-related gene expression mechanism by Y21 thromboxane A2 Minoru Hirano, Toshio Tanaka Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 37-37, 2005. |
---|
![]() |
Participation in regulatory mechanism and clinical condition of the renin-angiotensin-aldosterone system in the S1 kidney West 1, Yamanari, 2, Yoichi Abe 1, Hiroyuki Kobori 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 38-38, 2005. |
---|
![]() |
Effects of the renin-angiotensin-aldosterone system to S2 glomerulus hemodynamics and the physiological pathophysiological significance Hideji Arima Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 39-39, 2005. |
---|
![]() |
S3 renin-angiotensin aldosterone and Rho/Rho kinase system 脇野修, Takeshi Kanda, Takao Saruta, Koichi Hayashi Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 40-40, 2005. |
---|
![]() |
Role in the cardiovascular remodeling of the S4 chymase Shinji Takai, Tokuo Kim, Michiko Muramatsu, Mizuo Miyazaki Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 41-41, 2005. |
---|
![]() |
It is a role of nitroso thiol in the blood pressure regulation fixed-quantity of O1 small molecule and high polymer nitroso thiol Takaharu Ishibashi, Tomoko Miwa, Ikumi Shinkawa, Junko Yoshida, 西尾眞友 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 42-42, 2005. |
---|
![]() |
Role of the V1a adrenal cortex receptor subtype in the O2 normal blood pressure maintenance 輿水崇鏡 1, Nasa Yoshihisa 2, Akito Tanoe 3, Rei Oikawa 2, Yasushi Seino 4, 桑木共之 3, Yutaka Mori tree 6, Satoru Takeo 2, Gozo Tsujimoto 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 43-43, 2005. |
---|
![]() |
O3 oxidation LDL receptor LOX-1 is involved in vessel walls fatty deposition of SHR-SP induced by high fat diet Tatsuya Sawamura, Atsushi Nakano, Fumiaki Sugawara Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 44-44, 2005. |
---|
![]() |
Effect to give to cerebral blood flow and a blood-brain barrier of the NO purinergic nerve excitement to influence O4 cerebral artery Cheap mansion Kazuhide, Kazuya Shinozaki, Hills and rivers Kohei, Tomio Okamura Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 45-45, 2005. |
---|
![]() |
COX2 expression of vascular endothelial cells instruction with the O5 ATP Isao Matsuoka, Tang swallow, Junko Kimura Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 46-46, 2005. |
---|
![]() |
New regulatory mechanism of the L-form Ca2+ channel in O6 atrial muscle cells Satoru Akabane beauty 1, Excellent black success 2, Hidenori Ichijo 2, 水流弘通 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 15: 47-47, 2005. |
---|